BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

CT

Cellula Therapeutics at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

Cellula Therapeutics takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions centre on clinical strategy and funding, covering how to plan the development of rare disease therapeutics and how mission-driven capital can back therapies outside traditional venture models. The rare disease session is shared with Allinky Biopharma and Gibela Therapeutics.

OrganizationBIO-Europe 2026 Attendance
CT
Cellula Therapeutics
Epalinges, Switzerland
Biotech
Swiss cell therapy biotech spun out of the University of Geneva.
Panel
Wed Nov 11
10:30–10:55
Building a Clinical Strategy for Rare Disease Therapeutics
How bold trial designs, such as adaptive trials and basket trials testing one drug in several diseases, can help a first-of-its-kind therapy succeed.
with Allinky Biopharma, Gibela Therapeutics
Panel
Wed Nov 11
11:00–11:45
Capital with a Mission: Investing Beyond Traditional Venture Models
How mission-driven and foundation investors fund neglected diseases such as glioblastoma and neuroblastoma that venture capital passes over, focusing on Switzerland.
with Remora Biotech, Ampleia, Argobio

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Cellula Therapeutics

Tell us what you sell and we’ll find the people at Cellula Therapeutics most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction